Inflammatory myopathies

Expansion of exhausted CD8+ T cells associates with increased pulmonary fungal infection risk in anti-melanoma differentiation associated gene 5 dermatomyositis

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

CD8 T cells from patients with anti-MDA5+ DM show significant exhausted phenotype, and increased exhausted CD8 T cells were associated with high risk of pulmonary fungal infection.

Study context

Population
Patients with idiopathic inflammatory myopathy (IIM) (anti-MDA5+ dermatomyositis (DM), anti-MDA5- DM, anti-synthetase syndrome (ASS)) and healthy controls71 IIM patients · 29 healthy controls (HCs)
Participants
42 / 18 / 11 / 29
Exposure
Anti-MDA5+ DM vs anti-MDA5- IIM vs healthy controls
  • Anti-MDA5+ DMn = 42
  • Anti-MDA5- DMn = 18
  • ASSn = 11
  • HCsn = 29reference
Outcome
Abundance and clinical relevance of exhaustion markers (PD-1, TIM-3, LAG-3) on peripheral CD8 T cells
Methodological detailsflow cytometry
  • Flow cytometry

Main finding

As reported in the abstract

Exhaustion markers (LAG-3, TIM-3, PD-1) on CD8 T cells
  • Anti-MDA5+ DM vs Anti-MDA5- IIM or HCs: adjusted p all < 0.05
  • Anti-MDA5+ DM vs HCs: p all < 0.05

Observational data: associations, not effects.

Further findings

Pulmonary fungal infection: high vs lower level of PD-1+TIM-3+LAG-3+ CD8+ T cells (anti-MDA5+ DM)

Patients with high level of PD-1+TIM-3+LAG-3+ CD8+ T cells had a significantly higher incidence of pulmonary fungal infections but lower counts of CD4+ and CD8+ T cells

Prediction of pulmonary fungal infections by frequency of PD-1+TIM-3+LAG-3+CD8+ T cells (ROC analysis)

AUC
0.828

Original publication

Expansion of exhausted CD8+ T cells associates with increased pulmonary fungal infection risk in anti-melanoma differentiation associated gene 5 dermatomyositis. Clin Exp Rheumatol. Published 11 April 2023. doi:10.55563/clinexprheumatol/e51d3m

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.